7 Best Medical Technology Stocks To Buy According To Analysts

2. Bruker Corporation (NASDAQ:BRKR)

Price Target Upside: 44.18%

Bruker Corporation (NASDAQ:BRKR) stands second among the best medical technology stocks to buy according to analysts. It is a leading provider of scientific instruments and analytical solutions, specializing in mass spectrometers, X-ray technologies, magnetic resonance instruments, and optical spectroscopy tools. The company serves a wide range of sectors, including life science research, pharmaceuticals, biotechnology, academia, and industrial markets.

Bruker Corporation (NASDAQ:BRKR) reported strong financial results for Q4 2024, with revenue of $979.6 million, a 14.6% year-over-year increase. Organic revenue grew by 3.9%, and non-GAAP EPS rose by 8.6% to $0.76. Free cash flow for the quarter was $151.1 million. For the full year, the corporation generated $3.37 billion in revenue, reflecting a 13.6% increase, and expects 11% to 13% EPS growth in 2025. The company’s growth was driven by strong international performance, recovery in the biopharma sector, and strong results in markets like microbiology, semiconductors, AI, and applied sciences.

Additionally, Bruker Corporation (NASDAQ:BRKR) acquired NanoString, which may temporarily dilute operating margins in Q1 2025 but is expected to provide long-term strategic benefits, with a near breakeven outlook for 2026.